Gujarat Themis Biosyn Limited (GUJTHEM.BO)
BSE
Healthcare
Medical - Pharmaceuticals
$349.05
▲ +0.46%
Market Cap
$38.03B
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Beta
0.34
52-Wk Range
225.75-479.45
CEO
Sachin Dinesh Patel
Country
IN
Currency
INR
Gujarat Themis Biosyn Limited operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Mumbai, MA, IN. The stock last traded at $349.05, up 0.46% on the session, giving a market capitalisation of $38.03B. Its beta of 0.34 implies it has historically moved less than the broad market.
Company profile
Exchange
Bombay Stock Exchange
Employees
159
IPO date
2002-01-02
Headquarters
Mumbai, MA, IN
About Gujarat Themis Biosyn Limited
Gujarat Themis Biosyn Limited functions as a pharmaceutical company, specializing in the production of various drugs. Its key pharmaceutical offerings include Rifamycin and Lovastatin. The company was incorporated on December 11, 1981, and maintains its headquarters in Mumbai, India.
Comparable companies
Gujarat Themis Biosyn Limited is most often compared with the following Healthcare names:
More research on GUJTHEM.BO
Open full interactive analysis & DCF →